Skip to main content

Publications

featured publications

  • Post hoc longitudinal assessment of efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B.

    Blood advances

    Authors: Amy D Shapiro, Roshni Daniel Kulkarni, Margaret V Ragni, Herve Chambost, Johnny N Mahlangu, Johannes Oldenburg, Beatrice Nolan, Margareth C Ozelo, Meredith C Foster, Annemieke Willemze, Chris Barnowski, Nisha Jain, Bent Winding, Jennifer Dumont, Stefan Lethagen, Chris Barnes, K John Pasi

  • Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.

    The New England journal of medicine

    Authors: Johnny Mahlangu, Radoslaw Kaczmarek, Annette von Drygalski, Susan Shapiro, Sheng-Chieh Chou, Margareth C Ozelo, Gili Kenet, Flora Peyvandi, Michael Wang, Bella Madan, Nigel S Key, Michael Laffan, Amy L Dunn, Jane Mason, Doris V Quon, Emily Symington, Andrew D Leavitt, Johannes Oldenburg, Hervé Chambost, Mark T Reding, Kala Jayaram, Hua Yu, Reena Mahajan, Konstantia-Maria Chavele, Divya B Reddy, Joshua Henshaw, Tara M Robinson, Wing Yen Wong, Steven W Pipe

  • HIV-Associated Microbial Translocation May Affect Cytokine Production of CD56bright NK Cells via Stimulation of Monocytes.

    The Journal of infectious diseases

    Authors: Michael ToVinh, Gregor Hörr, Christoph Hoffmeister, Kristiyana Dobrikova, Christina Gotter, Jan Raabe, Kim M Kaiser, Sarah Ahmad, Claudia Finnemann, Eyleen Matejec, Gudrun Hack, Jenny Bischoff, Gereon J Rieke, Carolynne Schwarze-Zander, Christoph Boesecke, Kathrin van Bremen, Jan-Christian Wasmuth, Anna M Eis-Hübinger, Hendrik Streeck, Hedda L Verhasselt, Johannes Oldenburg, Christian P Strassburg, Jürgen K Rockstroh, Ulrich Spengler, Benjamin Krämer, Jacob Nattermann

  • Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study.

    The Lancet. Haematology

    Authors: Claude Négrier, Johnny Mahlangu, Michaela Lehle, Pratima Chowdary, Olivier Catalani, Ronald J Bernardi, Víctor Jiménez-Yuste, Benjamin M Beckermann, Christophe Schmitt, Giuliana Ventriglia, Jerzy Windyga, Roseline d'Oiron, Paul Moorehead, Sunita Koparkar, Vanda Teodoro, Amy D Shapiro, Johannes Oldenburg, Cedric Hermans

  • Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A.

    The New England journal of medicine

    Authors: Annette von Drygalski, Pratima Chowdary, Roshni Kulkarni, Sophie Susen, Barbara A Konkle, Johannes Oldenburg, Davide Matino, Robert Klamroth, Angela C Weyand, Victor Jimenez-Yuste, Keiji Nogami, Stacey Poloskey, Bent Winding, Annemieke Willemze, Karin Knobe

  • Mitochondria: Emerging Consequential in Sickle Cell Disease.

    Journal of clinical medicine

    Authors: Mohammad S Akhter, Hassan A Hamali, Hina Rashid, Gasim Dobie, Aymen M Madkhali, Abdullah A Mobarki, Johannes Oldenburg, Arijit Biswas

  • von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.

    Journal of thrombosis and haemostasis : JTH

    Authors: Maria Teresa Pagliari, Ulrich Budde, Luciano Baronciani, Peyman Eshghi, Minoo Ahmadinejad, Zahra Badiee, Mohammad-Reza Baghaipour, Olga Benítez Hidalgo, Eugenia Biguzzi, Imre Bodó, Giancarlo Castaman, Jenny Goudemand, Mehran Karimi, Bijan Keikhaei, Riitta Lassila, Frank W G Leebeek, Maria Fernanda Lopez Fernandez, Renato Marino, Johannes Oldenburg, Ian Peake, Cristina Santoro, Reinhard Schneppenheim, Andreas Tiede, Gholamreza Toogeh, Alberto Tosetto, Marc Trossaert, Hamideh Yadegari, Eva M K Zetterberg, Pier Mannuccio Mannucci, Augusto B Federici, Jeroen Eikenboom, Flora Peyvandi

  • Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies.

    Blood advances

    Authors: Rebecca Kruse-Jarres, Flora Peyvandi, Johannes Oldenburg, Tiffany Chang, Sammy Chebon, Michelle Y Doral, Stacy E Croteau, Thierry Lambert, Christine L Kempton, Steven W Pipe, Richard H Ko, Benjamin Trzaskoma, Christophe Dhalluin, Nives Selak Bienz, Markus Niggli, Michaela Lehle, Ido Paz-Priel, Guy Young, Víctor Jiménez-Yuste

  • Gene Therapy for Hemophilia-Opportunities and Risks.

    Deutsches Arzteblatt international

    Authors: Wolfgang Miesbach, Robert Klamroth, Johannes Oldenburg, Andreas Tiede

  • Insights into the Molecular Genetic of Hemophilia A and Hemophilia B: The Relevance of Genetic Testing in Routine Clinical Practice.

    Hamostaseologie

    Authors: Behnaz Pezeshkpoor, Johannes Oldenburg, Anna Pavlova